An intravitreal injection of N-omega-nitro-L-arginine methyl ester (L-NAME; an inhibitor of NOS) inhibits myopia development in the two most widely used animal myopia models: form deprivation myopia (FDM) and lens-induced myopia (LIM). This evidence concerns the gene NOS2 and myopia.